TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
HQH

Tekla Healthcare Investors

Financial Services · Asset Management

19.80$ -2.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Tekla Healthcare Investors (HQH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,097 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HQH
Line item 1996 1997 1998 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
148 208 158 486 330 243 292 372 419 387 445 408 365 376 382 511 691 1,054 1,118 1,010 1,067 1,085 878 1,056 1,173 926 932 1,061 1,097
0.3 – 0.4 1.2 3.0 1.7 2.1 0.9 4.8 2.6 0.1 2.1 0.5 1.4 5.2 0.3 0.2 44 61 58 33 19 27 6.8 12 43 40 0.6 2.6
0.3 – 0.2 0.3 0.6 – 2.0 0.2 0.3 0.0 0.0 0.0 – – – – – 0.0 0.2 0.0 6.5 0.0 1.7 -2.5 0.0 0.0 0.0 0.0 0.0
0.3 – 0.2 0.3 0.6 – 2.0 0.2 0.3 – – – – – – – – 0.0 0.2 0.0 6.5 0.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0
– – 0.2 0.9 2.4 1.7 0.1 0.7 4.5 2.6 0.1 2.1 0.5 1.4 5.2 0.3 0.2 7.3 1.9 9.6 0.2 0.5 9.0 4.3 4.0 2.9 6.9 0.5 2.5
– – – – – – – – – – – – – – – – – – – – – – 27 – 24 51 0.0 – –
0.7 0.3 0.2 0.8 1.0 0.5 4.7 2.3 1.4 1.8 0.7 4.5 9.1 10 2.7 0.6 0.9 1.1 14 35 9.8 3.8 6.9 1.1 16 9.7 1.1 1.4 3.4
0.5 – – – 0.5 – 4.2 1.7 0.8 1.2 – 3.8 8.5 9.6 2.1 – – 1.1 14 35 9.8 3.8 6.9 1.1 16 9.7 1.1 1.4 1.2
– – – – – – – – – – – – – – – – – – – 0.0 0.0 0.0 0.0 0.0 11 8.5 – – –
– – – – – – – – – 1.8 0.7 4.5 – – – – – – 12 34 8.6 2.6 6.0 – – – – – 1.2
148 208 158 486 329 242 287 369 417 385 444 403 356 365 379 510 690 1,053 1,104 975 1,058 1,082 871 1,055 1,157 917 931 1,060 1,094
– – – – – – – – – 26 70 17 – – – – – 432 433 262 308 297 75 240 303 25 6.0 118 102
5.9 9.2 9.7 11 12 14 15 21 22 23 23 24 25 25 26 27 28 36 37 39 41 42 43 44 45 47 49 52 54

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?